FDA Adverse Event Injury Summary report: N

TOTAL ASR ACET IMP SIZE 52

MDR report key: 2925863 · Received January 22, 2013

Report

Report Number
1818910-2013-01042
Event Type
Injury
Date Received
January 22, 2013
Date of Event
August 20, 2012
Report Date
June 17, 2014
Manufacturer
DEPUY INTERNATIONAL LTD. 8010379
Product Code
KWA
Removal / Correction Number
Z-1749/1816-2011
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
GM
Reporter Occupation
PATIENT

Narratives

Additional Manufacturer Narrative · 1

THE ASR PLATFORM WAS VOLUNTARILY RECALLED FROM THE MARKET IN AUGUST 2010, AND THE ASR PRODUCT CODES ARE NOW CONSIDERED INACTIVE. FURTHER INVESTIGATION OF THIS INDIVIDUAL INCIDENT WILL NOT BE UNDERTAKEN, AS THERE IS AN ONGOING INVESTIGATION REGARDING THE ROOT CAUSE(S) AND/OR CORRECTIVE ACTIONS. (B)(4).

Additional Manufacturer Narrative · 1

THIS COMPLAINT IS STILL UNDER INVESTIGATION. DEPUY WILL NOTIFY THE FDA OF THE RESULTS OF THIS INVESTIGATION ONCE IT HAS BEEN COMPLETED. THE CORRECTION/REMOVAL REPORTING NUMBER LISTED APPLIES TO THE CORRESPONDING PRODUCT CODE SOLD DOMESTICALLY.

Additional Manufacturer Narrative · 1

IF INFORMATION IS OBTAINED THAT WAS NOT AVAILABLE FOR THE INITIAL MEDWATCH, A FOLLOW-UP MEDWATCH WILL BE FILED AS APPROPRIATE. DEPUY STILL CONSIDERS THIS CASE CLOSED TO CAPA.

Description of Event or Problem · 1

ASR REVISION; ASR HIP RESURFACING SYSTEM - RIGHT HIP; REASON FOR REVISION: COMPONENT LOOSENING - ACETABULAR CUP.

Description of Event or Problem · 1

NEW (B)(6) RECORD CREATED IN ORDER TO UPDATE (B)(6) (LEGACY SYSTEM) COMPLAINT NUMBER (B)(4). REASON FOR ORIGINAL COMPLAINT - ASR REVISION. HIP(S) TO BE REVISED: RIGHT. TYPE OF HIP REPLACEMENT PRODUCT: ASR HIP RESURFACING SYSTEM. REASON(S) FOR REVISION: COMPONENT LOOSENING: ACETABULAR CUP. UPDATE RECEIVED 17TH JUNE 2014. ADDITIONAL HOSPITAL ADDED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
29588 TOTAL ASR ACET IMP SIZE 52 HIP ACETABULAR CUP KWA DEPUY INTERNATIONAL LTD. 8010379 2152920

Patients

Seq Age Sex Outcome Treatment
1 Required Intervention